WallStreetZenWallStreetZen

NASDAQ: XERS
Xeris Biopharma Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Xeris Biopharma Holdings earnings were $554.0k for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest XERS earnings report on Dec 31, 2025 announced Q4 2025 earnings of $11.1M, up 1,684.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, XERS reported annual earnings of $554.0k, with -101% growth. The next XERS earnings date is May 7, 2026.

XERS earnings history

Current Revenue
$291.8M
Current Earnings
$554.0k
Current Profit Margin
0.2%

XERS Return on Equity

Current Company
-5.3%
Current Industry
-10.3%
Current Market
29.2%
XERS's Return on Equity (-5.3%)... subscribe to Premium to read more.
High Return on Equity Performance

XERS Return on Assets

Current Company
0.2%
Current Industry
-6.9%
XERS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XERS announces earnings.

XERS Return on Capital Employed

Current Company
10.82%
Current Industry
-1.2%
XERS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XERS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XERS$42.33M$554.00kN/A$0.00
QURE-$116.59M-$198.97MN/A-$3.46
VALN-$83.01M-$132.40MN/A-$1.56
CMPX-$65.02M-$66.49MN/A-$0.42
GHRS-$47.46M-$48.26MN/A-$0.79
View Top Biotech Stocks

XERS earnings dates

Next earnings date
May 7, 2026

Xeris Biopharma Holdings Earnings Reports & History FAQ

What were Xeris Biopharma Holdings's earnings last quarter?

On XERS's earnings call on Invalid Date, Xeris Biopharma Holdings (NASDAQ: XERS) reported Q4 2025 earnings per share (EPS) of $0.07, up 333.33% year over year. Total XERS earnings for the quarter were $11.08 million. In the same quarter last year, Xeris Biopharma Holdings's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Xeris Biopharma Holdings stock.

When does Xeris Biopharma Holdings report earnings?

The next XERS earnings call is Invalid Date. Add XERS to your watchlist to be reminded of Xeris Biopharma Holdings's next earnings date.

Is Xeris Biopharma Holdings profitable or losing money?

As of the last Xeris Biopharma Holdings earnings report, Xeris Biopharma Holdings is currently profitable. Xeris Biopharma Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $554.00 thousand, a 101.01% decrease year over year.

What was XERS's earnings growth in the past year?

As of Xeris Biopharma Holdings's earnings date in Invalid Date, Xeris Biopharma Holdings's earnings has grown year over year. XERS earnings in the past year totalled $554.00 thousand.

What are Xeris Biopharma Holdings's earnings expectations?

The current EPS estimate for Xeris Biopharma Holdings's earnings report in Invalid Date is $0.01.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.